We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current 22UA market cap is 25.96B. The company's latest EPS is EUR and P/E is N/A.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 108.59M | 482.33M | 18.98B | 17.31B | 3.82B |
| Operating Income | -181.52M | -82.42M | 14.92B | 12.3B | 874.8M |
| Net Income | -179.06M | 15.2M | 10.29B | 9.43B | 930.3M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 797.65M | 2.32B | 15.83B | 23.28B | 23.01B |
| Total Liabilities | 304.16M | 946.77M | 3.94B | 3.22B | 2.76B |
| Total Equity | 493.49M | 1.37B | 11.89B | 20.06B | 20.25B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -198.54M | -13.47M | 889.7M | 13.58B | 5.37B |
| Investing | -77.12M | -144.85M | -566.1M | -35.3M | -6.95B |
| Financing | 383.29M | 894.73M | 94.2M | -1.42B | -778.6M |
| Market Cap | 25.96B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 237.73M |
| Average Volume (1 week) | 38.2k |
| Average Volume (1 Month) | 44.6k |
| 52 Week Change | 14.95% |
| 52 Week High | 118.50 |
| 52 Week Low | 69.55 |
| Spread (Intraday) | 0 (0%) |
| Company Name | BioNTech SE |
| Address |
an der goldgrube 12 mainz 55131 |
| Website | https://www.biontech.de |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
